Nothing Special   »   [go: up one dir, main page]

TW256834B - - Google Patents

Info

Publication number
TW256834B
TW256834B TW082107085A TW82107085A TW256834B TW 256834 B TW256834 B TW 256834B TW 082107085 A TW082107085 A TW 082107085A TW 82107085 A TW82107085 A TW 82107085A TW 256834 B TW256834 B TW 256834B
Authority
TW
Taiwan
Prior art keywords
radical
cycloalkyl
alkyl
phenyl
cycloalkylalkyl
Prior art date
Application number
TW082107085A
Other languages
English (en)
Inventor
George Wermuth Camille
Original Assignee
Elf Sanofi Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elf Sanofi Co filed Critical Elf Sanofi Co
Application granted granted Critical
Publication of TW256834B publication Critical patent/TW256834B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW082107085A 1992-06-24 1993-08-31 TW256834B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929207736A FR2692893B1 (fr) 1992-06-24 1992-06-24 Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
TW256834B true TW256834B (zh) 1995-09-11

Family

ID=9431129

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082107085A TW256834B (zh) 1992-06-24 1993-08-31

Country Status (30)

Country Link
US (1) US5464847A (zh)
EP (1) EP0576350B1 (zh)
JP (1) JPH0656809A (zh)
KR (1) KR100228813B1 (zh)
CN (1) CN1035552C (zh)
AT (1) ATE159721T1 (zh)
AU (1) AU665256B2 (zh)
BR (1) BR9302643A (zh)
CA (1) CA2099062A1 (zh)
CZ (1) CZ125293A3 (zh)
DE (1) DE69314855T2 (zh)
DK (1) DK0576350T3 (zh)
ES (1) ES2110070T3 (zh)
FI (1) FI932909A (zh)
FR (1) FR2692893B1 (zh)
GR (1) GR3025684T3 (zh)
HK (1) HK1002632A1 (zh)
HU (1) HUT66384A (zh)
IL (1) IL106088A (zh)
IS (1) IS4040A (zh)
MX (1) MX9303770A (zh)
MY (1) MY109557A (zh)
NO (1) NO303118B1 (zh)
NZ (1) NZ247949A (zh)
PH (1) PH30921A (zh)
PL (2) PL176103B1 (zh)
RU (1) RU2102389C1 (zh)
SG (1) SG50626A1 (zh)
SI (1) SI9300337A (zh)
TW (1) TW256834B (zh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714059B1 (fr) * 1993-12-21 1996-03-08 Sanofi Elf Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE4401912A1 (de) * 1994-01-24 1995-07-27 Basf Ag Methinfarbstoffe in der nichtlinearen Optik
US5646152A (en) 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2735777B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
AU703096B2 (en) 1995-10-17 1999-03-18 Neurocrine Biosciences, Inc. Amino substituted pyrimidines and triazines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US5861398A (en) * 1996-08-26 1999-01-19 Alanex Corporation Benzoperimidine-carboxylic acids and derivatives thereof
US6159980A (en) * 1996-09-16 2000-12-12 Dupont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
FR2754258B1 (fr) * 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
CA2281525A1 (en) 1997-02-18 1998-08-20 Neurocrine Biosciences, Inc. Biazacyclic crf antagonists
TR200102178T2 (tr) 1998-11-12 2002-01-21 Neurocrine Biosciences, Inc. CRF reseptör antagonistleri ve bunlarla ilgili yöntemler.
NZ510955A (en) 1998-11-12 2003-01-31 Neurocrine Biosciences Inc Tricyclic nitrogen containing ring system useful as CRF receptor antagonists
US6531475B1 (en) * 1998-11-12 2003-03-11 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2796380B3 (fr) 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
US6699866B2 (en) * 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
US7276526B2 (en) 2001-07-13 2007-10-02 Bristol-Myers Squibb Pharma Company Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
EP1423113A4 (en) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS
EP1285914B1 (en) * 2001-08-13 2007-12-19 PheneX Pharmaceuticals AG Nr1h4 nuclear receptor binding compounds
JP4484439B2 (ja) * 2002-03-14 2010-06-16 国立大学法人東京工業大学 Vdac調節剤
AU2003213351A1 (en) * 2002-03-14 2003-09-22 Takeda Chemical Industries, Ltd. Vdac regulator
EA013249B1 (ru) * 2003-12-26 2010-04-30 Киова Хакко Кирин Ко., Лтд. Производные тиазола
AU2007210014B2 (en) * 2006-02-01 2012-11-01 Merck Sharp & Dohme Corp. Potassium channel inhibitors
CN101528710B (zh) * 2006-10-19 2012-11-07 弗·哈夫曼-拉罗切有限公司 氨基甲基-4-咪唑类
JP5467735B2 (ja) * 2007-07-02 2014-04-09 東ソー株式会社 円筒形スパッタリングターゲット
RS65839B1 (sr) 2014-01-21 2024-09-30 Neurocrine Biosciences Inc Crf1 receptor antagonisti za tretman kongenitalne adrenalne hiperplazije
EP3846793B1 (en) 2018-09-07 2024-01-24 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof
EP3984523A1 (en) 2018-12-07 2022-04-20 Neurocrine Biosciences, Inc. Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia
IL296139A (en) 2020-03-03 2022-11-01 Pic Therapeutics Inc Eif4e inhibitors and uses thereof
WO2023028238A1 (en) 2021-08-25 2023-03-02 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264134A (en) * 1978-05-26 1981-04-28 Elliott Brothers (London) Limited Display arrangements
DK150068C (da) * 1978-06-02 1987-06-29 Pfizer Analogifremgangsmaade til fremstilling af aminothiazoler
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
US5232921A (en) * 1987-03-12 1993-08-03 Sanofi Thiazole derivatives active on the cholinergic system, process for obtention and pharmaceutical compositions
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.

Also Published As

Publication number Publication date
MX9303770A (es) 1994-05-31
DK0576350T3 (da) 1998-07-20
AU4139993A (en) 1994-01-06
EP0576350A1 (fr) 1993-12-29
KR940000447A (ko) 1994-01-03
SG50626A1 (en) 1998-07-20
PL176103B1 (pl) 1999-04-30
GR3025684T3 (en) 1998-03-31
PL299445A1 (en) 1994-01-24
PH30921A (en) 1997-12-23
FI932909A0 (fi) 1993-06-23
CA2099062A1 (en) 1993-12-25
EP0576350B1 (fr) 1997-10-29
ATE159721T1 (de) 1997-11-15
RU2102389C1 (ru) 1998-01-20
FR2692893A1 (fr) 1993-12-31
FR2692893B1 (fr) 1994-09-02
NO303118B1 (no) 1998-06-02
US5464847A (en) 1995-11-07
JPH0656809A (ja) 1994-03-01
IS4040A (is) 1993-12-25
DE69314855D1 (de) 1997-12-04
AU665256B2 (en) 1995-12-21
HK1002632A1 (en) 1998-09-04
PL174734B1 (pl) 1998-09-30
MY109557A (en) 1997-02-28
IL106088A (en) 1997-09-30
BR9302643A (pt) 1994-01-11
SI9300337A (en) 1994-03-31
CN1085898A (zh) 1994-04-27
HUT66384A (en) 1994-11-28
DE69314855T2 (de) 1998-05-20
CZ125293A3 (en) 1994-01-19
IL106088A0 (en) 1993-10-20
KR100228813B1 (ko) 1999-11-01
NZ247949A (en) 1994-10-26
HU9301850D0 (en) 1993-09-28
FI932909A (fi) 1993-12-25
ES2110070T3 (es) 1998-02-01
NO932319L (no) 1993-12-27
CN1035552C (zh) 1997-08-06
NO932319D0 (no) 1993-06-23

Similar Documents

Publication Publication Date Title
TW256834B (zh)
YU166891A (sh) Herbicidni supstituisani aril haloalkil pirazoli
MY107655A (en) Derivatives of benzofuran,benzothiophene,indole and indolizine,process for their preparation as well as the compositions containing them
DE3874845D1 (de) Substituierte triazolinone.
HUT45845A (en) Insecticides and acaricides and process for producing 1-aryl-pyrazole derivatives applicable as active ingredient
DE3879653D1 (de) Virusinhibierende heterocyclische verbindungen.
EP0485219A3 (en) Medicaments for preventing and treating circulatory organ diseases containing spiro-3-heteroazolidine compounds
ATE66221T1 (de) Substituierte 5-amino-pyrazole und diese enthaltende fungizide.
DK360388D0 (da) Laegemiddel til behandling af hjerteinsufficiens
FI860145A0 (fi) Herbicider av typ n-(fosfonometylglycyl)sulfonylaminer.
IL76215A0 (en) Benzodisultams,their preparation and their use as herbicides
TW337983B (en) 1, 3-oxazn-4-one derivatives, their preparation and uses
ES8606862A1 (es) Procedimiento para la obtencion de nuevas n-fosforil-o n-tiofosforil-n'-s-triacinil-formamidinas
EP0717045A4 (en) METHOD FOR PRODUCING INDOLOCARBAZOL DERIVATIVES
EP0481289B1 (de) N-Fumaramidsäurederivate und diese enthaltende Fungizide.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees